Drugs / TER-2013
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07109726 | Sep 2025 → Dec 2028 expected | breast cancer, cervical cancer, endometrial cancer, esophageal squamous cell carcinoma +3 | Terremoto Biosciences Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TER-2013 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07109726 ↗ |
| Route | Oral | “Oral Capsules” NCT07109726 ↗ |